In a new update to Australian guidelines for the clinical care of patients with COVID-19, prophylactic doses of anticoagulants, preferably LMWH have been recommended for the prevention of VTE. “Use prophylactic doses of anticoagulants, preferably LMWH (e.g. enoxaparin 40 mg once daily or dalteparin 5000 IU once daily) in adults with moderate COVID-19 or other ...
Anticoagulant DVT prophylaxis recommended for Australians with COVID-19
21 May 2020